Profile data is unavailable for this security.
About the company
TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).
- Revenue in USD (TTM)1.30m
- Net income in USD-7.70m
- Incorporated2010
- Employees1.00
- LocationTherapeuticsMD Inc951 Yamato Road, Suite 220BOCA RATON 33431United StatesUSA
- Phone+1 (561) 961-1900
- Websitehttps://www.therapeuticsmd.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AIM ImmunoTech Inc | 202.00k | -28.96m | 20.28m | 26.00 | -- | 2.09 | -- | 100.42 | -0.595 | -0.595 | 0.0042 | 0.2084 | 0.0068 | -- | 0.1413 | 7,769.23 | -96.75 | -45.64 | -116.18 | -48.35 | 79.21 | -231.75 | -14,337.62 | -11,695.01 | -- | -- | 0.00 | -- | 43.26 | -11.26 | -48.94 | -- | 35.73 | -- |
| RenovoRx Inc | 0.00 | -10.23m | 20.41m | 8.00 | -- | -- | -- | -- | -1.01 | -1.01 | 0.00 | -0.2805 | 0.00 | -- | -- | 0.00 | -234.38 | -- | -317.07 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -3.47 | -- | -- | -- |
| MEI Pharma Inc | 72.65m | 19.84m | 20.65m | 46.00 | 1.04 | 0.3472 | 1.02 | 0.2843 | 2.98 | 2.98 | 10.90 | 8.93 | 0.6425 | -- | 25.47 | 1,579,304.00 | 17.55 | -25.31 | 20.31 | -28.59 | -- | -- | 27.32 | -122.05 | -- | -- | 0.00 | -- | 19.95 | 97.56 | 41.53 | -- | -- | -- |
| CERo Therapeutics Holdings Inc | 0.00 | -2.54m | 20.76m | 8.00 | -- | -- | -- | -- | -0.3796 | -0.3796 | 0.00 | -0.9226 | 0.00 | -- | -- | 0.00 | -9.96 | -- | -33.80 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -279.82 | -- | -- | -- |
| Evaxion Biotech A/S - ADR | 73.00k | -22.13m | 21.49m | 49.00 | -- | -- | -- | 294.33 | -81.29 | -81.29 | 0.2665 | -1.25 | 0.0042 | -- | 0.091 | 1,489.80 | -126.74 | -100.11 | -183.85 | -131.65 | -- | -- | -30,308.22 | -131,560.30 | -- | -30.92 | 1.77 | -- | -- | -- | 4.51 | -- | 65.53 | -- |
| TherapeuticsMD Inc | 1.30m | -7.70m | 21.57m | 1.00 | -- | 0.7363 | -- | 16.56 | -0.7466 | -1.00 | 0.1249 | 2.54 | 0.0195 | -- | -- | 1,302,000.00 | -11.51 | -53.35 | -19.23 | -111.61 | 100.00 | 86.67 | -591.32 | -236.57 | -- | -- | 0.00 | -- | -98.14 | -39.53 | -816.85 | -- | -- | -- |
| Synlogic Inc | 3.37m | -57.28m | 21.66m | 6.00 | -- | 0.4006 | -- | 6.43 | -11.41 | -11.41 | 0.6581 | 4.64 | 0.0362 | -- | -- | 561,833.30 | -61.46 | -40.57 | -74.45 | -43.82 | -- | -- | -1,699.26 | -3,245.93 | -- | -- | 0.00009 | -- | 185.68 | 5.99 | 13.40 | -- | -48.05 | -- |
| Biora Therapeutics Inc | 4.00k | -124.33m | 21.78m | 58.00 | -- | -- | -- | 5,445.37 | -8.57 | -8.56 | 0.0003 | -4.28 | 0.00009 | -- | 0.0048 | 68.97 | -293.45 | -122.84 | -- | -369.01 | -- | -- | -3,108,350.00 | -415.10 | -- | -- | -- | -- | -98.69 | -87.44 | -154.63 | -- | -53.68 | -- |
| Neurosense Therapeutics Ltd | 0.00 | -11.28m | 21.84m | 16.00 | -- | -- | -- | -- | -0.7625 | -0.7625 | 0.00 | -0.1219 | 0.00 | -- | -- | 0.00 | -207.24 | -- | -395.72 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 8.59 | -- | -- | -- |
| Context Therapeutics Inc | 0.00 | -23.96m | 22.03m | 5.00 | -- | 1.86 | -- | -- | -1.50 | -1.50 | 0.00 | 0.7435 | 0.00 | -- | -- | 0.00 | -88.71 | -- | -102.79 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -61.53 | -- | -- | -- |
| Lisata Therapeutics Inc | 0.00 | -20.84m | 22.10m | 25.00 | -- | 0.4503 | -- | -- | -2.58 | -2.58 | 0.00 | 5.91 | 0.00 | -- | -- | 0.00 | -32.63 | -45.97 | -36.16 | -50.47 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 61.57 | -- | -- | -- |
| Zivo Bioscience Inc | 27.65k | -7.78m | 22.22m | 8.00 | -- | -- | -- | 803.66 | -4.62 | -4.62 | 0.0163 | -0.9259 | 0.0206 | -- | -- | 3,456.25 | -580.66 | -376.60 | -- | -- | 41.99 | -- | -28,127.23 | -96,315.32 | -- | -97.39 | -- | -- | -- | -- | 11.07 | -- | -- | -- |
| Lumos Pharma Inc | 2.05m | -34.03m | 22.40m | 33.00 | -- | 0.819 | -- | 10.92 | -4.19 | -4.19 | 0.2526 | 3.37 | 0.0363 | -- | 9.47 | 62,151.52 | -60.27 | -29.78 | -68.62 | -32.32 | -- | -- | -1,659.39 | -2,937.61 | -- | -- | 0.00 | -- | 34.67 | -30.31 | -9.57 | -- | -- | -- |
| Eom Pharmaceutical Holdings Inc | 0.00 | -4.93m | 22.42m | 3.00 | -- | -- | -- | -- | -0.0435 | -0.0435 | 0.00 | -0.0212 | -- | -- | -- | 0.00 | -- | -126.34 | -- | -171.37 | -- | -- | -- | -- | -- | -- | 7.41 | -- | -- | -- | -254.37 | -- | -- | -- |
| Bullfrog AI Holdings, Inc. | 65.00k | -5.36m | 22.45m | 4.00 | -- | 6.72 | -- | 345.42 | -0.9042 | -0.9042 | 0.0108 | 0.4253 | 0.0455 | -- | -- | 16,250.00 | -374.94 | -- | -- | -- | 92.00 | -- | -8,239.82 | -- | -- | -67.87 | 0.00 | -- | 550.00 | -- | -91.11 | -- | -- | -- |
Data as of Apr 25 2024. Currency figures normalised to TherapeuticsMD Inc's reporting currency: US Dollar USD
29.67%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Rubric Capital Management LPas of 31 Dec 2023 | 1.19m | 11.27% |
| Clearline Capital LPas of 31 Dec 2023 | 466.21k | 4.41% |
| Tejara Capital Ltd.as of 31 Dec 2023 | 401.94k | 3.80% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 382.65k | 3.62% |
| Adar1 Capital Management LLCas of 31 Dec 2023 | 272.16k | 2.57% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 135.00k | 1.28% |
| Morgan Stanley & Co. LLCas of 31 Dec 2023 | 130.59k | 1.24% |
| Geode Capital Management LLCas of 31 Dec 2023 | 84.79k | 0.80% |
| Bridgeway Capital Management LLCas of 31 Dec 2023 | 42.00k | 0.40% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 30.10k | 0.29% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
